We are live on ! Find out more
ACM

Adalta Capital Management Portfolio holdings

AUM $209M
1-Year Est. Return 19.54%
This Fund
S&P 500
This Quarter Est. Return
+6.59%
1 Year Est. Return
+19.54%
3 Year Est. Return
+66.34%
5 Year Est. Return
+69.73%
10 Year Est. Return
–
AUM
$140M
AUM Growth
-$1.45M
Cap. Flow
-$8.82M
Cap. Flow %
-6.3%
Top 10 Hldgs %
40.19%
Holding
88
New
7
Increased
21
Reduced
12
Closed
8

Top Buys

Rank Stock Value
1
STLA icon
Stellantis
STLA
+$2.54M
2
BOX icon
Box
BOX
+$1.83M
3
TEVA icon
Teva Pharmaceuticals
TEVA
+$761K
4
BABA icon
Alibaba
BABA
+$637K
5
WFC icon
Wells Fargo
WFC
+$588K

Top Sells

Rank Stock Value
1
FMI
Foundation Medicine, Inc.
FMI
+$16.9M
2
PHG icon
Philips
PHG
+$478K
3
PAC icon
Grupo Aeroportuario del Pacifico
PAC
+$444K
4
TSM icon
TSMC
TSM
+$439K
5
KNDI
Kandi Technologies Group
KNDI
+$348K

Sector Composition

Rank Sector Weight
1 Financials 18.49%
2 Technology 15.38%
3 Industrials 13.66%
4 Consumer Discretionary 13.16%
5 Energy 10.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNI icon
26
Canadian National Railway
CNI
$76.9B
$1.82M 1.3%
20,300
– –
WFC icon
27
Wells Fargo
WFC
$261B
$1.59M 1.13%
30,225
+10,300
+52% +$588K
FCE.A
28
DELISTED
Forest City Realty Trust, Inc.
FCE.A
$1.58M 1.13%
63,110
-10,862
-15% -$265K
OKE icon
29
Oneok
OKE
$57.2B
$1.45M 1.03%
21,397
– –
LUMN icon
30
Lumen
LUMN
$6.57B
$1.39M 0.99%
65,320
+25,977
+66% +$544K
USB icon
31
US Bancorp
USB
$98.2B
$1.37M 0.98%
25,814
– –
PM icon
32
Philip Morris
PM
$297B
$1.28M 0.91%
15,449
-75
-0.5% -$6.16K
BMY icon
33
Bristol-Myers Squibb
BMY
$133B
$1.28M 0.91%
20,548
– –
BAX icon
34
Baxter International
BAX
$13.5B
$1.27M 0.91%
16,400
– –
ENB icon
35
Enbridge
ENB
$119B
$1.15M 0.82%
35,719
– –
DVN icon
36
Devon Energy
DVN
$52.1B
$1.05M 0.75%
26,250
– –
OBE
37
Obsidian Energy
OBE
$716M
$1.04M 0.74%
156,876
+34,928
+29% +$249K
BWA icon
38
BorgWarner
BWA
$13.1B
$1.03M 0.74%
27,480
+114
+0.4% +$4.48K
BIDU icon
39
Baidu
BIDU
$37.7B
$977K 0.7%
4,271
– –
YELP icon
40
Yelp
YELP
$1.45B
$912K 0.65%
18,531
+2,990
+19% +$131K
XOM icon
41
ExxonMobil
XOM
$644B
$870K 0.62%
10,236
-1,050
-9% -$85.8K
AAPL icon
42
Apple
AAPL
$4.54T
$807K 0.58%
14,308
– –
NEE icon
43
NextEra Energy
NEE
$181B
$752K 0.54%
17,940
– –
CAJ
44
DELISTED
Canon, Inc.
CAJ
$737K 0.53%
23,300
-5,000
-18% -$158K
ACGL icon
45
Arch Capital
ACGL
$34.3B
$728K 0.52%
24,410
+1,700
+7% +$50.5K
STM icon
46
STMicroelectronics
STM
$46.7B
$711K 0.51%
38,778
+12,500
+48% +$259K
TEVA icon
47
Teva Pharmaceuticals
TEVA
$40.8B
$707K 0.5%
+32,800
New +$761K
CLLS
48
Cellectis
CLLS
$277M
$651K 0.46%
23,075
+1,175
+5% +$33.8K
BEP icon
49
Brookfield Renewable
BEP
$9.97B
$649K 0.46%
40,270
+282
+0.7% +$4.63K
ED icon
50
Consolidated Edison
ED
$40.1B
$615K 0.44%
8,075
– –
1
2
3 4

Similar funds

GCM
Glynn Capital Management Menlo Park, California $209M AUM 31.14% 1-Year Est. Return
BCM
Beartown Capital Management Huntington Woods, Michigan $209M AUM
AL
ADE LLC Baltimore, Maryland $209M AUM 15.13% 1-Year Est. Return
MIM
Marshall Investment Management Littleton, Colorado $208M AUM 30.96% 1-Year Est. Return
BSCCG
Blue Sky Capital Consultants Group Poway, California $210M AUM 28.65% 1-Year Est. Return
EM
ELCO Management New York $208M AUM 23.85% 1-Year Est. Return
GHP
Great Hill Partners Boston, Massachusetts $210M AUM 134.81% 1-Year Est. Return
RWRC
R.W. Roge & Company Bohemia, New York $210M AUM 18.75% 1-Year Est. Return

Adalta Capital Management's Q3 2018 Portfolio in Review

As of Q3 2018, Adalta Capital Management held 88 positions worth $140M, down 1% from $142M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Adalta Capital Management withdrew a net $8.82M in Q3 2018, closing 8 positions and reducing 12 holdings. Its most notable exit was Foundation Medicine, Inc., an estimated $16.9M position sold in full.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 16% a quarter earlier, followed by Technology and Industrials.

Against the trend, Adalta Capital Management opened a new position in Teva Pharmaceuticals worth $707K.

  • Adalta Capital Management's largest Q3 2018 buy was Teva Pharmaceuticals: 32,800 shares worth $707K.
  • Adalta Capital Management added most to Stellantis in Q3 2018, an estimated $2.54M increase.
  • Adalta Capital Management's biggest Q3 2018 reduction was Forest City Realty Trust, Inc., cutting an estimated $265K.
  • Adalta Capital Management fully exited Foundation Medicine, Inc. in Q3 2018, selling an estimated $16.9M.
  • Adalta Capital Management's ten largest holdings make up 40% of its $140M portfolio in Q3 2018.
  • Adalta Capital Management opened 7 new positions and closed 8 in Q3 2018.
  • Adalta Capital Management's portfolio value fell 1% quarter-over-quarter to $140M.

Based on Adalta Capital Management's 13F filing for Q3 2018, filed 14 Nov 2018.